Randall Moreadith
Vorstandsvorsitzender bei Serina Therapeutics, Inc.
Vermögen: - $ am 30.04.2024
Profil
Randall W.
Moreadith is currently the President, Chief Executive Officer & Director at Serina Therapeutics (AL), Inc., the President, Chief Executive Officer & Director at Canaria Therapeutics, Inc., and the Chief Development Officer at Serina Therapeutics, Inc. He previously held positions as the Chief Medical Officer at Renovis, Inc., the Principal Medical Officer at Quintiles, Inc. (California), the Chief Medical Officer at Tissue Repair Co., the Chief Medical Officer at Post-Hypothermia Corp., the Chief Medical Officer & Executive Vice President at Taxus Cardium Pharmaceuticals Group, Inc., the President & Chief Operating Officer at Oxurion NV, and the Chief Development Officer & SVP-Drug Development at Nektar Therapeutics.
Dr. Moreadith holds a doctorate degree from Duke University and The Johns Hopkins University, and an undergraduate degree from North Carolina State University.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
-.--% | 26.03.2024 | 0 ( -.--% ) | - $ | 30.04.2024 |
Aktive Positionen von Randall Moreadith
Unternehmen | Position | Beginn |
---|---|---|
Serina Therapeutics, Inc.
Serina Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Serina Therapeutics, Inc. is a pharmaceutical company, which engages in the development of polymer technology. Its POZ technology is designed to optimize drug delivery to maximize compliance, therapeutic outcomes, safety, and quality of life for patients. It also offers drugs to treat neurological diseases, cancer, and pain. The company was founded by J. Milton Harris and Michael D. Bentley in 2006 and is headquartered in Huntsville, AL. | Vorstandsvorsitzender | 01.09.2010 |
Canaria Therapeutics, Inc.
Canaria Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Canaria Therapeutics, Inc. operates as a biotechnology company. The company was founded in 2018 and is headquartered in Huntsville, AL. | Vorstandsvorsitzender | - |
Ehemalige bekannte Positionen von Randall Moreadith
Unternehmen | Position | Ende |
---|---|---|
NEKTAR THERAPEUTICS | Corporate Officer/Principal | 01.12.2009 |
Tissue Repair Co.
Tissue Repair Co. Medical SpecialtiesHealth Technology Tissue Repair Co. develops biopharmaceutical products for tissue regeneration. It is a biopharmaceutical company with a clinical-stage focus on products that promote tissue repair. Its scientific expertise is based on gene therapy, growth factor biology, tissue regeneration and product development. The company is headquartered in San Diego, CA | Technik-/Wissenschafts-/F&E-Leiter | 02.01.2007 |
Renovis, Inc.
Renovis, Inc. Pharmaceuticals: MajorHealth Technology Renovis, Inc. develops pharmaceutical products. The company discovers, develops, and commercializes novel therapeutics for neurological and inflammatory diseases. It is headquartered in San Francisco, CA | Technik-/Wissenschafts-/F&E-Leiter | 16.12.2005 |
OXURION NV | Präsident | 01.01.2002 |
Quintiles, Inc. (California)
Quintiles, Inc. (California) Medical/Nursing ServicesHealth Services Quintiles, Inc. provides therapeutic services. It offers medical services, information and partnering solutions to the pharmaceutical, biotechnology and healthcare industries. The company was founded in 1982 and is headquartered in San Francisco, CA. | Technik-/Wissenschafts-/F&E-Leiter | 01.02.1997 |
Ausbildung von Randall Moreadith
Duke University | Doctorate Degree |
The Johns Hopkins University | Doctorate Degree |
North Carolina State University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 3 |
---|---|
GENE BIOTHERAPEUTICS, INC. | Health Technology |
OXURION NV | Health Technology |
NEKTAR THERAPEUTICS | Health Technology |
Private Unternehmen | 6 |
---|---|
Renovis, Inc.
Renovis, Inc. Pharmaceuticals: MajorHealth Technology Renovis, Inc. develops pharmaceutical products. The company discovers, develops, and commercializes novel therapeutics for neurological and inflammatory diseases. It is headquartered in San Francisco, CA | Health Technology |
Tissue Repair Co.
Tissue Repair Co. Medical SpecialtiesHealth Technology Tissue Repair Co. develops biopharmaceutical products for tissue regeneration. It is a biopharmaceutical company with a clinical-stage focus on products that promote tissue repair. Its scientific expertise is based on gene therapy, growth factor biology, tissue regeneration and product development. The company is headquartered in San Diego, CA | Health Technology |
Post-Hypothermia Corp.
Post-Hypothermia Corp. Medical SpecialtiesHealth Technology Post-Hypothermia Corp. develops and provides temperature modulation therapy products for the healthcare industry. It also provides CoolBlue, a surface-based temperature modulation system that consists of a console and a disposable CoolBlue vest with upper thigh pads, which is designed for use in less acute patients or prolonged temperature management clinical settings. The company was founded by John D. Dobak in 1998 and is headquartered in San Diego, CA. | Health Technology |
Quintiles, Inc. (California)
Quintiles, Inc. (California) Medical/Nursing ServicesHealth Services Quintiles, Inc. provides therapeutic services. It offers medical services, information and partnering solutions to the pharmaceutical, biotechnology and healthcare industries. The company was founded in 1982 and is headquartered in San Francisco, CA. | Health Services |
Serina Therapeutics, Inc.
Serina Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Serina Therapeutics, Inc. is a pharmaceutical company, which engages in the development of polymer technology. Its POZ technology is designed to optimize drug delivery to maximize compliance, therapeutic outcomes, safety, and quality of life for patients. It also offers drugs to treat neurological diseases, cancer, and pain. The company was founded by J. Milton Harris and Michael D. Bentley in 2006 and is headquartered in Huntsville, AL. | Commercial Services |
Canaria Therapeutics, Inc.
Canaria Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Canaria Therapeutics, Inc. operates as a biotechnology company. The company was founded in 2018 and is headquartered in Huntsville, AL. | Health Technology |